MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
about
MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@en
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@nl
type
label
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@en
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@nl
prefLabel
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@en
MiR-10a-5p targets TFAP2C to p ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P1476
MiR-10a-5p targets TFAP2C to p ...... ncreatic ductal adenocarcinoma
@en
P2093
Guangbing Xiong
Lianfang Zheng
Mengyu Feng
Suli Zheng
Taiping Zhang
Yupei Zhao
P2860
P2888
P356
10.1186/S13046-018-0739-X
P50
P577
2018-04-03T00:00:00Z
P6179
1103128380